Prostate cancer

Editorial

M K Brawer. J Urol. 1997 Jan.

. 1997 Jan;157(1):207-8.

doi: 10.1016/s0022-5347(01)65326-6.

No abstract available

Comment on

Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./ml.
Irani J, Millet C, Levillain P, Doré B, Begon F, Aubert J. Irani J, et al. J Urol. 1997 Jan;157(1):185-8. doi: 10.1016/s0022-5347(01)65319-9. J Urol. 1997. PMID: 8976247 Clinical Trial.
Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?
Prestigiacomo AF, Stamey TA. Prestigiacomo AF, et al. J Urol. 1997 Jan;157(1):189-94. J Urol. 1997. PMID: 8976248
Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, Catalona WJ. Ornstein DK, et al. J Urol. 1997 Jan;157(1):195-8. J Urol. 1997. PMID: 8976249 Clinical Trial.
Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate.
Eskew LA, Bare RL, McCullough DL. Eskew LA, et al. J Urol. 1997 Jan;157(1):199-202; discussion 202-3. J Urol. 1997. PMID: 8976250 Clinical Trial.
Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated.
Terris MK, Pham TQ, Issa MM, Kabalin JN. Terris MK, et al. J Urol. 1997 Jan;157(1):204-6. J Urol. 1997. PMID: 8976251